Lawyer Turned Stem Cell Advocate Susan Solomon Dies at 71

Her passion came from her son’s struggle with type 1 diabetes and the inability to find new treatments.

Written byLisa Winter
| 2 min read
Susan Solomon looking into the camera
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Susan Solomon, cofounder of the New York Stem Cell Foundation, died on September 8 at age 71 after a years-long journey with ovarian cancer. Solomon, who had been a lawyer, became an advocate for biomedical research in response to health issues in her family. She went on to cofound one of the largest stem cell research nonprofits in the world.

Solomon was born August 23, 1951 in Brooklyn, New York, to a record executive father and a pianist mother. She attended the Ethical Culture Fieldston School before marrying drummer Gary Hirsh, with whom she had one son before divorcing. She graduated from New York University with a history degree in 1975. Three years later, she obtained her law degree from Rutgers University before beginning a career that spanned several legal arenas, from workplace discrimination to corporate law to television programming.

In 1980, she married Paul Goldberger. The pair had two ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies